Unknown NA INTERVENTIONAL 4-arm NCT05587257

Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata

Sponsor: Assiut University

Conditions Alopecia Areata

Interventions Derma pen Fractional CO2 laser Minoxidil Topical Spray Niosome minoxidil

Updated 4 times since 2022 Last updated: Oct 16, 2022 Started: Jan 1, 2023 Primary completion: Jan 1, 2024 Completion: Feb 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alopecia Areata and is currently ongoing. Assiut University leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Nov 2024 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Nov 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.